Eli Lilly and Company: Diabetic Neuropathies trials

The registry lists 12 Diabetic Neuropathies studies with Eli Lilly and Company as lead sponsor. 0 are open to participants now and 8 have results posted.

Phase 2 1Phase 3 8Phase 4 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study in Participants With Diabetic Peripheral Neuropathic Pain in ChinaCompletedNCT01179672Phase 3Results posted
• A Study in Painful Diabetic NeuropathyCompletedNCT01089556Phase 3Results posted
• A Study for Treatment of Pain in Patients With Diabetic Neuropathy.CompletedNCT00785577Phase 2Results posted
• A Long-term Study for the Treatment of Painful Diabetic NeuropathyCompletedNCT00641719Phase 3Results posted
• A Study for the Treatment of Diabetic Peripheral Neuropathic PainCompletedNCT00552175Phase 3Results posted
• Duloxetine Versus Placebo in the Treatment of Patients With Diabetic Peripheral Neuropathic Pain in ChinaCompletedNCT00408993Phase 3Results posted
• An Open-Label Comparison of Duloxetine to Other Alternatives for the Management of Diabetic Peripheral Neuropathic PainCompletedNCT00385671Phase 4Results posted
• Maintenance of Effect of Duloxetine in Patients With Diabetic Peripheral Neuropathic Pain (DPNP)CompletedNCT00322621Phase 4Results posted
• Tolerability of Switching to Duloxetine for the Management of Diabetic Nerve PainCompletedNCT00266643Phase 4
• A Study for the Treatment of Painful Diabetic NeuropathyCompletedNCT00058968Phase 3
• Treatment of Peripheral Neuropathy in Patients With DiabetesCompletedNCT00044421Phase 3
• Treatment for Symptomatic Peripheral Neuropathy in Patients With DiabetesCompletedNCT00044395Phase 3